Stacey Honda to Treatment Outcome
This is a "connection" page, showing publications Stacey Honda has written about Treatment Outcome.
Connection Strength
0.058
-
Serous carcinomatous component championed by heparin-binding EGF-like growth factor (HB-EGF) predisposing to metastasis and recurrence in stage I uterine malignant mixed mullerian tumor. Hum Pathol. 2016 07; 53:159-67.
Score: 0.026
-
KRAS testing and epidermal growth factor receptor inhibitor treatment for colorectal cancer in community settings. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):91-101.
Score: 0.020
-
Insulinoma, a rare neuroendocrine tumor: a case report. Hawaii Med J. 2005 Jan; 64(1):9-11.
Score: 0.012